Scilex Holding Co, 10% Owner at Semnur Pharmaceuticals, Inc. (SMNR), sold 12,500,000 shares at $16.00 ($200.0M) on 2025-09-23, disclosed to the SEC on 2025-09-25.
Open-market sale of $200.0M SMNR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.00 | 554,849 | $8.9M | 4.4% |
| 2 | $16.00 | 11,945,151 | $191.1M | 95.6% |
| Total | $16.00 avg | 12,500,000 | $200.0M | 100% |
| Filing → |
| DVLT | SELL | 2025-12-31 | $17.6M | — | Filing → |
| SCLX | SELL | 2025-12-30 | $17.6M | — | Filing → |
| DVLT | SELL | 2025-11-28 | $1.7M | — | Filing → |